Desmond A Schatz, MD - Research

Research at a glance

Top areas of exploration

Diabetes Mellitus, Type 1 , 253 publications
Autoantibodies , 92 publications
Insulin , 68 publications
Islets of Langerhans , 49 publications

Research activity

381 publications

23,284 citations

Why is this important?

Active clinical trials

ITN095AI DESIGNATE

This is a multicenter, Phase Ib, open-label, siplizumab dose-finding study in individuals aged 8-45 years with a Type 1 diabetes mellitus (T1DM) diagnosis. within 18 months of V0. Participants will be randomized 1:1:1:1 to one of four possible鈥�

Investigator: Desmond A Schatz
Status: Accepting Candidates
Ages: 8 Years - 45 Years
Sexes: All

My publications

381 publications

2020

Insulin dose optimization using an automated artificial intelligence-based decision support system in youths with type 1 diabetes.

Nature medicine

鈥�

2020

Insulin-Like Growth Factor Dysregulation Both Preceding and Following Type 1 Diabetes Diagnosis

Diabetes

鈥�

2020

Introducing the Endotype Concept to Address the Challenge of Disease Heterogeneity in Type 1 Diabetes.

Diabetes care

鈥�

2020

Multiplexing DNA methylation markers to detect circulating cell-free DNA derived from human pancreatic 尾 cells.

JCI insight

鈥�

2020

Slowed Metabolic Decline After 1 Year of Oral Insulin Treatment Among Individuals at High Risk for Type 1 Diabetes in the Diabetes Prevention Trial-Type 1 (DPT-1) and TrialNet Oral Insulin Prevention Trials.

Diabetes

鈥�

BOB体育

Desmond A Schatz, MD : Research

Research at a glance

Top areas of exploration

Research activity

Active clinical trials

My publications

Insulin dose optimization using an automated artificial intelligence-based decision support system in youths with type 1 diabetes.

Insulin-Like Growth Factor Dysregulation Both Preceding and Following Type 1 Diabetes Diagnosis

Introducing the Endotype Concept to Address the Challenge of Disease Heterogeneity in Type 1 Diabetes.

Multiplexing DNA methylation markers to detect circulating cell-free DNA derived from human pancreatic 尾 cells.

Slowed Metabolic Decline After 1 Year of Oral Insulin Treatment Among Individuals at High Risk for Type 1 Diabetes in the Diabetes Prevention Trial-Type 1 (DPT-1) and TrialNet Oral Insulin Prevention Trials.

BOB体育

Research at a glance

Top areas of exploration

Research activity

Active clinical trials

My publications

Filter publications

Insulin dose optimization using an automated artificial intelligence-based decision support system in youths with type 1 diabetes.

Insulin-Like Growth Factor Dysregulation Both Preceding and Following Type 1 Diabetes Diagnosis

Introducing the Endotype Concept to Address the Challenge of Disease Heterogeneity in Type 1 Diabetes.

Multiplexing DNA methylation markers to detect circulating cell-free DNA derived from human pancreatic 尾 cells.

Slowed Metabolic Decline After 1 Year of Oral Insulin Treatment Among Individuals at High Risk for Type 1 Diabetes in the Diabetes Prevention Trial-Type 1 (DPT-1) and TrialNet Oral Insulin Prevention Trials.